𝔖 Bobbio Scriptorium
✦   LIBER   ✦

IGF-1 and IGFBP-3: Risk of prostate cancer among men in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial

✍ Scribed by Jocelyn M. Weiss; Wen-Yi Huang; Sabina Rinaldi; Thomas R. Fears; Nilanjan Chatterjee; David Chia; E. David Crawford; Rudolf Kaaks; Richard B. Hayes

Publisher
John Wiley and Sons
Year
2007
Tongue
French
Weight
91 KB
Volume
121
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

IGF‐1 and IGFBP‐3 may influence risk of prostate cancer through their roles in cellular growth, metabolism and apoptosis, however, epidemiologic results have been inconsistent. The role of obesity in prostate cancer risk is not clearly understood, but hyperinsulinemia‐related increases in bioactive IGF‐1 levels, associated with obesity, could be a component of the relationship between the IGF‐axis and prostate cancer. We conducted a nested case–control study in the prospective Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial to examine associations between IGF‐1 and IGFBP‐3 and risk of prostate cancer. A total of 727 incident prostate cancer cases and 887 matched controls were selected for this analysis. There was no clear overall association between IGF‐1, IGFBP‐3 and IGF‐1:IGFBP‐3 molar ratio (IGFmr) and prostate cancer risk, however, IGFmr was associated with risk in obese men (BMI > 30, __p‐__trend = 0.04), with a greater than 2‐fold increased risk in the highest IGFmr quartile (OR 2.34, 95% CI 1.10–5.01). Risk was specifically increased for aggressive disease in obese men (OR 2.80, 95% CI 1.11–7.08). In summary, our large prospective study showed no overall association between the insulin‐like growth factor axis and prostate cancer risk, however, IGFmr was related to risk for aggressive prostate cancer in obese men. © 2007 Wiley‐Liss, Inc.

📜 SIMILAR VOLUMES

The prostate, lung, colorectal, and ovar
The prostate, lung, colorectal, and ovarian cancer screening trial of the national cancer institute
✍ John K. Gohagan; Philip C. Prorok; Barnett S. Kramer; Richard B. Hayes; Joyce E. 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 481 KB 👁 2 views

The two-year pilot phase of the Prostate, Lung, Colorectal, and Ovarian (PLCO) trial concluded September 29, 1994. The goals, organization, operation, and recruitment status of the trial are discussed. The PLCO trial is a 16year randomized controlled screening trial involving 148,000 male and female

Large-scale randomized prostate cancer s
Large-scale randomized prostate cancer screening trials: Program performances in the European randomized screening for prostate cancer trial and the prostate, lung, colorectal and ovary cancer trial
✍ Harry J. de Koning; Anssi Auvinen; Antonio Berenguer Sanchez; Fernando Calais da 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 79 KB 👁 2 views

## Abstract Two large‐scale randomized screening trials, the Prostate, Lung, Colorectal and Ovary (PLCO) cancer trial in the USA and the European Randomized Screening for Prostate Cancer (ERSPC) trial in Europe are currently under way, aimed at assessing whether screening reduces prostate cancer mo

Adherence to repeat screening flexible s
Adherence to repeat screening flexible sigmoidoscopy in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial
✍ Joel L. Weissfeld; Bruce S. Ling; Robert E. Schoen; Robert S. Bresalier; Thomas 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB 👁 2 views

## Abstract ## BACKGROUND Acceptance of screening flexible sigmoidoscopy has been poor, in part because of providers' concerns regarding the acceptability of the procedure. In the current prospective study, the authors used adherence to repeat testing to assess the acceptability of screening flexi

Pancreatic cancer risk: Associations wit
Pancreatic cancer risk: Associations with meat-derived carcinogen intake in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO) cohort
✍ Kristin E. Anderson; Steven J. Mongin; Rashmi Sinha; Rachael Stolzenberg-Solomon 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 104 KB 👁 1 views

## Abstract ## Background Epidemiological studies report positive associations between high‐temperature cooked meat intake and pancreatic cancer. We assessed associations between dietary intake of heterocyclic amines (HCAs) and benzo(__a__)pyrene (BaP)—mutagens formed in meat cooked at high temper

No effect of meat, meat cooking preferen
No effect of meat, meat cooking preferences, meat mutagens or heme iron on lung cancer risk in the prostate, lung, colorectal and ovarian cancer screening trial
✍ Nataša Tasevska; Amanda J. Cross; Kevin W. Dodd; Regina G. Ziegler; Neil E. Capo 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 168 KB 👁 2 views

Recent epidemiological studies have suggested that red and processed meat may increase the risk of lung cancer. Possible underlying mechanisms include mutagens produced during high-temperature cooking or preservation, or formed endogenously from heme iron in meat. We used data from 99,579 participan